It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Starter Kits

A little something to get you started

Starter Kits are our way of celebrating the first step in your treatment journey with Omnitrope®!

We know that beginning a new treatment can be tricky. Thatʼs why we send you your very own Starter Kit to help you make a smooth transition as you introduce Omnitrope into your daily routine. 

Because no two growth journeys are the same, our new Starter Kits are available in a variety of choices. Speak to your doctor about ordering yours today!

Take a look at our choice of Starter Kits:

Kids 12 and below (purple)

Kids 12 and below purple

Kids 12 and below (green)

Kids 12 and below Green

Patient 13+

Starter Kit 13+
Your supports

What is a growth-related disorder?

From routine check-up, to testing and treatment options. What is a growth-related disorder and how is it diagnosed?

Your Treatment Options

What are my treatment options?

Take the next steps by looking at your Omnitrope treatment options and speak to your doctor about which one may work for you.

What is a growth-related disorder

Your
supports

There’s a whole community of support groups out there working with patients with growth-related disorders.

Get started with OmniSource today

Omnisource

Personalized support, each step of the way. Click here to enroll.

INDICATIONS

Omnitrope is a prescription medicine that contains human growth hormone and is used to treat:

  • Children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome, and Idiopathic Short Stature
  • Adults with either adult onset or childhood onset GHD

IMPORTANT SAFETY INFORMATION

Who should not take Omnitrope®?

Omnitrope should not be used by children or adults that have:

  • a critical illness caused by certain types of heart or stomach surgery, accidental trauma,  or a sudden and severe breathing problem (respiratory failure)
  • Prader-Willi syndrome who are severely overweight or have a history of breathing problems including sleep apnea
  • cancer or other tumors
  • allergies to growth hormone or any of the ingredients in the medicine
  • certain types of eye problems caused by diabetes
  • closed bone growth plates

What should patients tell their healthcare provider before taking Omnitrope?

Patients should tell their healthcare provider about all of their medical conditions, including if they:

  • have had heart or stomach surgery, trauma, or serious breathing problems
  • have or have had cancer or any tumor
  • have diabetes
  • take any prescription and non-prescription medicines, steroids, vitamins, or herbal supplements
  • are pregnant or breastfeeding, or plan to become pregnant or breastfeed

What are the most common side effects of Omnitrope?

  • local reactions at the injection site (such as pain, numbness, redness and swelling)
  • headaches
  • swelling associated with fluid retention
  • pain in joints and muscle pain
  • carpal tunnel syndrome
  • tingling and numbness
  • high blood sugar (hyperglycemia/diabetes) and sugar in your urine (glucosuria)
  • unusual skin sensations
  • low levels of thyroid hormone (hypothyroidism)

Other possible side effects of Omnitrope are:

  • return of tumor or cancerous growths
  • headaches, changes in vision, nausea or vomiting (these may be symptoms of raised pressure in the brain which requires immediate medical attention)
  • hip and knee pain or a limp in children, that can be a sign of slipped capital femoral epiphysis
  • worsening of pre-existing curvature of the spine in children (scoliosis)
  • increased ear infections and ear disorders in children with Turner syndrome; check for cardiovascular disorders (hypertension, stroke)
  • intense pain and tenderness in the abdomen as consequence of an inflammation of the pancreas (pancreatitis)
  • gasping syndrome (decreased rate of breathing) in children from high levels of benzyl alcohol (an inactive ingredient)
  • Increased mortality in patients with Prader Willi and acute illness

Please see full Prescribing Information for Omnitrope

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch